DOCSLIB.ORG

Mouse Tspyl5 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Tspyl5 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Tspyl5 Knockout Project (CRISPR/Cas9) Objective: To create a Tspyl5 knockout Mouse model (C57BL/6N) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Tspyl5 gene (NCBI Reference Sequence: NM_001085421 ; Ensembl: ENSMUSG00000038984 ) is located on Mouse chromosome 15. 1 exon is identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 1 (Transcript: ENSMUST00000042021). Exon 1 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 1 starts from about 0.08% of the coding region. Exon 1 covers 100.0% of the coding region. The size of effective KO region: ~1216 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 Legends Exon of mouse Tspyl5 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Page 3 of 8 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(28.35% 567) | C(21.6% 432) | T(26.1% 522) | G(23.95% 479) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(24.75% 495) | C(22.05% 441) | T(31.9% 638) | G(21.3% 426) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr15 - 33687798 33689797 2000 browser details YourSeq 436 5 594 2000 89.1% chr9 + 120682887 120683484 598 browser details YourSeq 417 5 611 2000 88.9% chr14 + 30688026 30688649 624 browser details YourSeq 415 5 608 2000 87.3% chr7 - 57637052 57637656 605 browser details YourSeq 414 5 598 2000 89.3% chr13 + 95297900 95298526 627 browser details YourSeq 413 5 607 2000 88.5% chr5 - 9366354 9366959 606 browser details YourSeq 413 5 594 2000 87.9% chr9 + 74983072 74983666 595 browser details YourSeq 412 19 594 2000 88.8% chr4 - 103044134 103044719 586 browser details YourSeq 411 5 612 2000 85.9% chr14 - 21916090 21916693 604 browser details YourSeq 411 29 611 2000 89.3% chr18 + 79908508 79909131 624 browser details YourSeq 411 19 606 2000 87.6% chr14 + 73439001 73439653 653 browser details YourSeq 409 25 605 2000 87.9% chr2 + 147505938 147506552 615 browser details YourSeq 408 5 592 2000 88.6% chr9 + 48312788 48313386 599 browser details YourSeq 407 5 606 2000 88.0% chr19 - 18034560 18035151 592 browser details YourSeq 405 28 594 2000 87.9% chr13 + 103925193 103925768 576 browser details YourSeq 404 5 606 2000 86.4% chr16 - 13277995 13278591 597 browser details YourSeq 403 25 589 2000 88.2% chr9 - 57783427 57783993 567 browser details YourSeq 402 5 594 2000 89.8% chr1 - 82609496 82610090 595 browser details YourSeq 400 10 610 2000 87.6% chr17 - 16470857 16471464 608 browser details YourSeq 400 5 591 2000 88.5% chr9 + 80082483 80083070 588 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr15 - 33684580 33686579 2000 browser details YourSeq 48 1595 1929 2000 96.3% chr10 - 39638764 39918341 279578 browser details YourSeq 29 1311 1367 2000 94.2% chr12 - 58312434 58312492 59 browser details YourSeq 26 821 847 2000 100.0% chr1 + 15301896 15301939 44 browser details YourSeq 23 399 421 2000 100.0% chrY - 4290334 4290356 23 browser details YourSeq 23 1652 1674 2000 100.0% chr12 + 113241316 113241338 23 browser details YourSeq 21 1229 1249 2000 100.0% chr16 + 49798636 49798656 21 browser details YourSeq 20 1213 1238 2000 88.5% chr4 + 72859671 72859696 26 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 8 https://www.alphaknockout.com Gene and protein information: Tspyl5 testis-specific protein, Y-encoded-like 5 [ Mus musculus (house mouse) ] Gene ID: 239364, updated on 12-Aug-2019 Gene summary Official Symbol Tspyl5 provided by MGI Official Full Name testis-specific protein, Y-encoded-like 5 provided by MGI Primary source MGI:MGI:2442458 See related Ensembl:ENSMUSG00000038984 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as 6330530B20; E130308C19Rik Orthologs human all Genomic context Location: 15; 15 B3.1 See Tspyl5 in Genome Data Viewer Exon count: 1 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 15 NC_000081.6 (33683875..33687883, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 15 NC_000081.5 (33613630..33617638, complement) Chromosome 15 - NC_000081.6 Page 6 of 8 https://www.alphaknockout.com Transcript information: This gene has 1 transcript Gene: Tspyl5 ENSMUSG00000038984 Description testis-specific protein, Y-encoded-like 5 [Source:MGI Symbol;Acc:MGI:2442458] Gene Synonyms E130308C19Rik Location Chromosome 15: 33,683,875-33,687,884 reverse strand. GRCm38:CM001008.2 About this gene This gene has 1 transcript (splice variant), 183 orthologues, 10 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Tspyl5-201 ENSMUST00000042021.4 4010 406aa ENSMUSP00000045542.3 Protein coding CCDS49591 Q69ZB3 TSL:NA GENCODE basic APPRIS P1 24.01 kb Forward strand 33.675Mb 33.680Mb 33.685Mb 33.690Mb 33.695Mb Contigs < AC129208.4 Genes (Comprehensive set... < Tspyl5-201protein coding Regulatory Build 33.675Mb 33.680Mb 33.685Mb 33.690Mb 33.695Mb Reverse strand 24.01 kb Regulation Legend CTCF Promoter Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000042021 < Tspyl5-201protein coding Reverse strand 4.01 kb ENSMUSP00000045... MobiDB lite Low complexity (Seg) Superfamily NAP-like superfamily Pfam Nucleosome assembly protein (NAP) PANTHER Nucleosome assembly protein (NAP) PTHR11875:SF30 Gene3D 3.30.1120.90 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend synonymous variant Scale bar 0 40 80 120 160 200 240 280 320 360 406 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Viewpoint, from the Literature, Most of the Genes in Our Sets Are Known to Be Strongly Related to Cancer
    BMC Bioinformatics BioMed Central Research Open Access A voting approach to identify a small number of highly predictive genes using multiple classifiers Md Rafiul Hassan*1, M Maruf Hossain*1, James Bailey1,2, Geoff Macintyre1,2, Joshua WK Ho3,4 and Kotagiri Ramamohanarao1,2 Address: 1Department of Computer Science and Software Engineering, The University of Melbourne, Victoria 3010, Australia, 2NICTA Victoria Laboratory, The University of Melbourne, Victoria 3010, Australia, 3School of Information Technologies, The University of Sydney, NSW 2006, Australia and 4NICTA, Australian Technology Park, Eveleigh, NSW 2015, Australia Email: Md Rafiul Hassan* - [email protected]; M Maruf Hossain* - [email protected]; James Bailey - [email protected]; Geoff Macintyre - [email protected]; Joshua WK Ho - [email protected]; Kotagiri Ramamohanarao - [email protected] * Corresponding authors from The Seventh Asia Pacific Bioinformatics Conference (APBC 2009) Beijing, China. 13–16 January 2009 Published: 30 January 2009 <supplement> <title> <p>Selected papers from the Seventh Asia-Pacific Bioinformatics Conference (APBC 2009)</p> </title> <editor>Michael Q Zhang, Michael S Waterman and Xuegong Zhang</editor> <note>Research</note> </supplement> BMC Bioinformatics 2009, 10(Suppl 1):S19 doi:10.1186/1471-2105-10-S1-S19 This article is available from: http://www.biomedcentral.com/1471-2105/10/S1/S19 © 2009 Hassan et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Epigenetic Reprogramming Underlies Efficacy of DNA Demethylation
    www.nature.com/scientificreports OPEN Epigenetic reprogramming underlies efcacy of DNA demethylation therapy in osteosarcomas Naofumi Asano 1,2, Hideyuki Takeshima3, Satoshi Yamashita3, Hironori Takamatsu2,3, Naoko Hattori3, Takashi Kubo4, Akihiko Yoshida5, Eisuke Kobayashi6, Robert Nakayama2, Morio Matsumoto2, Masaya Nakamura2, Hitoshi Ichikawa 4, Akira Kawai6, Tadashi Kondo1 & Toshikazu Ushijima 3* Osteosarcoma (OS) patients with metastasis or recurrent tumors still sufer from poor prognosis. Studies have indicated the efcacy of DNA demethylation therapy for OS, but the underlying mechanism is still unclear. Here, we aimed to clarify the mechanism of how epigenetic therapy has therapeutic efcacy in OS. Treatment of four OS cell lines with a DNA demethylating agent, 5-aza-2′- deoxycytidine (5-aza-dC) treatment, markedly suppressed their growth, and in vivo efcacy was further confrmed using two OS xenografts. Genome-wide DNA methylation analysis showed that 10 of 28 primary OS had large numbers of methylated CpG islands while the remaining 18 OS did not, clustering together with normal tissue samples and Ewing sarcoma samples. Among the genes aberrantly methylated in primary OS, genes involved in skeletal system morphogenesis were present. Searching for methylation-silenced genes by expression microarray screening of two OS cell lines after 5-aza-dC treatment revealed that multiple tumor-suppressor and osteo/chondrogenesis-related genes were re-activated by 5-aza-dC treatment of OS cells. Simultaneous activation of multiple genes related to osteogenesis and cell proliferation, namely epigenetic reprogramming, was considered to underlie the efcacy of DNA demethylation therapy in OS. Osteosarcoma (OS) is the most common malignant tumor of the bone in children and adolescents1.
    [Show full text]
  • Sex-Differential DNA Methylation and Associated Regulation Networks in Human Brain Implicated in the Sex-Biased Risks of Psychiatric Disorders
    Molecular Psychiatry https://doi.org/10.1038/s41380-019-0416-2 ARTICLE Sex-differential DNA methylation and associated regulation networks in human brain implicated in the sex-biased risks of psychiatric disorders 1,2 1,2 1 2 3 4 4 4 Yan Xia ● Rujia Dai ● Kangli Wang ● Chuan Jiao ● Chunling Zhang ● Yuchen Xu ● Honglei Li ● Xi Jing ● 1 1,5 2 6 1,2,7 1,2,8 Yu Chen ● Yi Jiang ● Richard F. Kopp ● Gina Giase ● Chao Chen ● Chunyu Liu Received: 8 November 2018 / Revised: 18 March 2019 / Accepted: 22 March 2019 © Springer Nature Limited 2019 Abstract Many psychiatric disorders are characterized by a strong sex difference, but the mechanisms behind sex-bias are not fully understood. DNA methylation plays important roles in regulating gene expression, ultimately impacting sexually different characteristics of the human brain. Most previous literature focused on DNA methylation alone without considering the regulatory network and its contribution to sex-bias of psychiatric disorders. Since DNA methylation acts in a complex regulatory network to connect genetic and environmental factors with high-order brain functions, we investigated the 1234567890();,: 1234567890();,: regulatory networks associated with different DNA methylation and assessed their contribution to the risks of psychiatric disorders. We compiled data from 1408 postmortem brain samples in 3 collections to identify sex-differentially methylated positions (DMPs) and regions (DMRs). We identified and replicated thousands of DMPs and DMRs. The DMR genes were enriched in neuronal related pathways. We extended the regulatory networks related to sex-differential methylation and psychiatric disorders by integrating methylation quantitative trait loci (meQTLs), gene expression, and protein–protein interaction data.
    [Show full text]
  • Gene Silencing of TSPYL5 Mediated by Aberrant Promoter Methylation in Gastric Cancers Yeonjoo Jung1, Jinah Park1, Yung-Jue Bang1,2 and Tae-You Kim1,2
    Laboratory Investigation (2008) 88, 153–160 & 2008 USCAP, Inc All rights reserved 0023-6837/08 $30.00 Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers Yeonjoo Jung1, Jinah Park1, Yung-Jue Bang1,2 and Tae-You Kim1,2 DNA methylation is crucial for normal development, but gene expression altered by DNA hypermethylation is often associated with human diseases, especially cancers. The gene TSPYL5, encoding testis-specific Y-like protein, was pre- viously identified in microarray screens for genes induced by the inhibition of DNA methylation and histone deacetylation in glioma cell lines. The TSPYL5 showed a high frequency of DNA methylation-mediated silencing in both glioma cell lines and primary glial tumors. We now report that TSPYL5 is also inactivated by DNA methylation and could be a putative epigenetic target gene in gastric cancers. We found that the expression of TSPYL5 mRNA was frequently downregulated and inversely correlated with DNA methylation in seven out of nine gastric cancer cell lines. TSPYL5 mRNA expression was also restored after treating with a DNA methyltransferase inhibitor. In primary gastric tumors, methylation-specific PCR results in 23 of the 36 (63.9%) cases revealed that the hypermethylation at CpG islands of the TSPYL5 was detectable at a high frequency. Furthermore, TSPYL5 suppressed the growth of gastric cancer cells as demonstrated by a colony for- mation assay. Thus, strong associations between TSPYL5 expression and hypermethylation were observed, and aberrant methylation at a CpG island of TSPYL5 may play an important role in development of gastric cancers. Laboratory Investigation (2008) 88, 153–160; doi:10.1038/labinvest.3700706; published online 3 December 2007 KEYWORDS: DNMT inhibitor; gastric cancer; NAP domain; promoter hypermethylation; TSPYL5 Epigenetic events are heritable modifications that regulate TSPYL6.
    [Show full text]
  • Rna-Sequencing Applications: Gene Expression Quantification and Methylator Phenotype Identification
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2013 RNA-SEQUENCING APPLICATIONS: GENE EXPRESSION QUANTIFICATION AND METHYLATOR PHENOTYPE IDENTIFICATION Guoshuai Cai Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Computational Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Cai, Guoshuai, "RNA-SEQUENCING APPLICATIONS: GENE EXPRESSION QUANTIFICATION AND METHYLATOR PHENOTYPE IDENTIFICATION" (2013). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 386. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/386 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. RNA-SEQUENCING APPLICATIONS: GENE EXPRESSION QUANTIFICATION AND METHYLATOR PHENOTYPE IDENTIFICATION
    [Show full text]
  • Single-Nucleotide Polymorphisms in the TSPYL-4 and NT5DC1 Genes Are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease
    MOLECULAR MEDICINE REPORTS 6: 631-638, 2012 Single-nucleotide polymorphisms in the TSPYL-4 and NT5DC1 genes are associated with susceptibility to chronic obstructive pulmonary disease YI GUO1*, YI GONG2*, GUOCHAO SHI1, KUN YANG1, CHUNMING PAN3, MIN LI1, QINGYUN LI1, QIJIAN CHENG1, RANRAN DAI1, LIANG FAN1 and HUANYING WAN1 1Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University (SJTU), School of Medicine; 2Department of Respiratory Medicine, Huashan Hospital, Fudan University; 3Ruijin Hospital, State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Jiao Tong University (SJTU), School of Medicine, Shanghai 200025, P.R. China Received February 12, 2012; Accepted June 18, 2012 DOI: 10.3892/mmr.2012.964 Abstract. The risk of developing chronic obstructive pulmo- block. We constructed the TSPYL-4 and NT5DC1 haplo- nary disease (COPD) is partially determined by genetic types of the cases and controls, but no significant difference and environmental factors. Many published candidate gene between the two groups was found. rs3749893 A allele of studies show conflicting results due to ethnic differences TSPYL-4 and rs1052443 C allele of NT5DC1 were associated and sample sizes. The number of these studies carried out in with a protective effect against the deterioration of pulmonary Chinese populations is small. To investigate candidate genes function. In conclusion, TSPYL-4 and NT5DC1 gene poly- and haplotypes for susceptibility to COPD in a southern morphisms are associated with susceptibility to COPD and Han Chinese population, we performed genotyping of DNA pulmonary function. samples in 200 COPD patients and 250 control subjects by analyzing 54 single-nucleotide polymorphisms (SNPs) in Introduction 23 genes associated with the development of COPD and/or pulmonary function identified by genome-wide association Chronic obstructive pulmonary disease (COPD) is expected studies (GWAS).
    [Show full text]
  • Pan-Cancer Transcriptome Analysis Reveals a Gene Expression
    Modern Pathology (2016) 29, 546–556 546 © 2016 USCAP, Inc All rights reserved 0893-3952/16 $32.00 Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin Qinghua Xu1,6, Jinying Chen1,6, Shujuan Ni2,3,4,6, Cong Tan2,3,4,6, Midie Xu2,3,4, Lei Dong2,3,4, Lin Yuan5, Qifeng Wang2,3,4 and Xiang Du2,3,4 1Canhelp Genomics, Hangzhou, Zhejiang, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; 4Institute of Pathology, Fudan University, Shanghai, China and 5Pathology Center, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China Carcinoma of unknown primary, wherein metastatic disease is present without an identifiable primary site, accounts for ~ 3–5% of all cancer diagnoses. Despite the development of multiple diagnostic workups, the success rate of primary site identification remains low. Determining the origin of tumor tissue is, thus, an important clinical application of molecular diagnostics. Previous studies have paved the way for gene expression-based tumor type classification. In this study, we have established a comprehensive database integrating microarray- and sequencing-based gene expression profiles of 16 674 tumor samples covering 22 common human tumor types. From this pan-cancer transcriptome database, we identified a 154-gene expression signature that discriminated the origin of tumor tissue with an overall leave-one-out cross-validation accuracy of 96.5%. The 154-gene expression signature was first validated on an independent test set consisting of 9626 primary tumors, of which 97.1% of cases were correctly classified.
    [Show full text]
  • Volume 18 - Number 1 January 2014
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Volume 18 - Number 1 January 2014 The PDF version of the Atlas of Genetics and Cytogenetics in Oncology and Haematology is a reissue of the original articles published in collaboration with the Institute for Scientific and Technical Information (INstitut de l’Information Scientifique et Technique - INIST) of the French National Center for Scientific Research (CNRS) on its electronic publishing platform I-Revues. Online and PDF versions of the Atlas of Genetics and Cytogenetics in Oncology and Haematology are hosted by INIST-CNRS. Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Scope The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a peer reviewed on-line journal in open access, devoted to genes, cytogenetics, and clinical entities in cancer, and cancer-prone diseases. It presents structured review articles (“cards”) on genes, leukaemias, solid tumours, cancer-prone diseases, and also more traditional review articles (“deep insights”) on the above subjects and on surrounding topics. It also present case reports in hematology and educational items in the various related topics for students in Medicine and in Sciences. Editorial correspondance Jean-Loup Huret Genetics, Department of Medical Information, University Hospital F-86021 Poitiers, France tel +33 5 49 44 45 46 or +33 5 49 45 47 67 [email protected] or [email protected] Staff Mohammad Ahmad, Mélanie Arsaban, Marie-Christine Jacquemot-Perbal, Vanessa Le Berre, Anne Malo, Carol Moreau, Catherine Morel-Pair, Laurent Rassinoux, Alain Zasadzinski. Philippe Dessen is the Database Director, and Alain Bernheim the Chairman of the on-line version (Gustave Roussy Institute – Villejuif – France).
    [Show full text]
  • UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent Permalink https://escholarship.org/uc/item/7m04f0b0 Author Buchholz, Kyle Stephen Publication Date 2016 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Cardiac Stretch-Induced Transcriptomic Changes are Axis-Dependent A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioengineering by Kyle Stephen Buchholz Committee in Charge: Professor Jeffrey Omens, Chair Professor Andrew McCulloch, Co-Chair Professor Ju Chen Professor Karen Christman Professor Robert Ross Professor Alexander Zambon 2016 Copyright Kyle Stephen Buchholz, 2016 All rights reserved Signature Page The Dissertation of Kyle Stephen Buchholz is approved and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California, San Diego 2016 iii Dedication To my beautiful wife, Rhia. iv Table of Contents Signature Page ................................................................................................................... iii Dedication .......................................................................................................................... iv Table of Contents ................................................................................................................ v List of Figures ...................................................................................................................
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Genetic Co-Expression Networks Contribute to Creating Predictive
    www.nature.com/scientificreports OPEN Genetic co‑expression networks contribute to creating predictive model and exploring novel biomarkers for the prognosis of breast cancer Yuan‑Kuei Li1,2,23, Huan‑Ming Hsu3,4,5,23, Meng‑Chiung Lin6,23, Chi‑Wen Chang7,8,9,23, Chi‑Ming Chu10,11,12,13,14,23, Yu‑Jia Chang15,16,23, Jyh‑Cherng Yu3, Chien‑Ting Chen10, Chen‑En Jian10, Chien‑An Sun11, Kang‑Hua Chen7,9, Ming‑Hao Kuo17, Chia‑Shiang Cheng18, Ya‑Ting Chang10, Yi‑Syuan Wu18, Hao‑Yi Wu10, Ya‑Ting Yang10, Chen Lin2,19, Hung‑Che Lin5,17,20, Je‑Ming Hu5,17,21,22 & Yu‑Tien Chang10,11* Genetic co‑expression network (GCN) analysis augments the understanding of breast cancer (BC). We aimed to propose GCN‑based modeling for BC relapse‑free survival (RFS) prediction and to discover novel biomarkers. We used GCN and Cox proportional hazard regression to create various prediction models using mRNA microarray of 920 tumors and conduct external validation using independent data of 1056 tumors. GCNs of 34 identifed candidate genes were plotted in various sizes. Compared to the reference model, the genetic predictors selected from bigger GCNs composed better prediction models. The prediction accuracy and AUC of 3 ~ 15‑year RFS are 71.0–81.4% and 74.6–78% respectively (rfm, ACC 63.2–65.5%, AUC 61.9–74.9%). The hazard ratios of risk scores of developing relapse ranged from 1.89 ~ 3.32 (p < ­10–8) over all models under the control of the node status. External validation showed the consistent fnding.
    [Show full text]
  • Enhanced Hemato-Endothelial Specification During Human Embryonic Differentiation Through Developmental Cooperation Between AF4-MLL and MLL-AF4 Fusions
    Acute Lymphoblastic Leukemia SUPPLEMENTARY APPENDIX Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions Clara Bueno, 1,2 Fernando J Calero-Nieto, 3 Xiaonan Wang, 3 Rafael Valdés-Mas, 4 Francisco Gutiérrez-Agüera, 1 Heleia Roca-Ho, 1 Veronica Ayllon, 5 Pedro J Real, 5 David Arambilet, 6 Lluis Espinosa, 6,2 Raul Torres-Ruiz, 1 Antonio Agraz- Doblas, 1,7 Ignacio Varela, 7 Jasper de Boer, 8 Anna Bigas, 6,2 Bertie Gottgens, 3 Rolf Marschalek 9 and Pablo Menendez 1,2,10 1Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Spain; 2Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain; 3Department of Hematology, Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK; 4Dreamgenics S.L. Oviedo. Spain; 5GENyO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalu - sian Regional Government and University of Granada, Department of Biochemistry and Molecular Biology, Granada, Spain; 6Programa de Cáncer, Instituto Hospital del Mar de Investigaciones Médicas. Barcelona. Spain; 7Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain; 8Cancer Section, UCL Great Ormond Street Institute of Child Health, London, UK; 9Institute of Pharmaceutical Biology, Goethe-University, Frankfurt, Ger - many and 10 Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain ©2019 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2018.202044 Received: July 18, 2018.
    [Show full text]